2025 Best of Breast - Clinical Case Discussions: 1) Metastatic, ER+ Case; 2) HER2 Positive Case

0:00 | Metastatic ER+ Case In this session, Reshma Mahtani (Miami Cancer Institute) and Ashwin Mehta (Memorial Healthcare System) will review a case of metastatic estrogen receptor-positive (ER+) breast cancer, examining current standards of care, novel therapeutic approaches, and strategies to overcome treatment resistance. 1:00:45 | HER2 Positive Case In this session, Neil Iyengar (Memorial Sloan Kettering Cancer Center) and Joseph Panoff (Miami Cancer Institute) will present a case of HER2-positive breast cancer, addressing optimal sequencing of HER2-targeted therapies, managing treatment-related toxicities, and integrating novel agents into clinical practice.

2025 Best of Breast: 1) Welcome; 2) Early Stage ER+ Case; 3) Early Stage Triple Negative Case
▶︎

2025 Best of Breast: 1) Welcome; 2) Early Stage ER+ Case; 3) Early Stage Triple Negative Case

New FDA-Approved Targeted Drug for Treatment-Resistant, ER Positive HER2 Negative Breast Cancer
▶︎

New FDA-Approved Targeted Drug for Treatment-Resistant, ER Positive HER2 Negative Breast Cancer

SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney
▶︎

SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
▶︎

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma

My Breast Cancer Came Back 20 Years Later! - Nikoo M l Breast Cancer l The Patient Story
▶︎

My Breast Cancer Came Back 20 Years Later! - Nikoo M l Breast Cancer l The Patient Story

Anti-HER2 Mechanisms of Approved HER2 Inhibitors
▶︎

Anti-HER2 Mechanisms of Approved HER2 Inhibitors

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

🩸Phlebotomy Certification Practice Test – 50 Questions to Help You PASS!
▶︎

🩸Phlebotomy Certification Practice Test – 50 Questions to Help You PASS!

HER2-Low Breast Cancer: Treatment Options and What You Should Know
▶︎

HER2-Low Breast Cancer: Treatment Options and What You Should Know

💉 100 Most Common Medical Prefixes | Medical Terminology Made Easy
▶︎

💉 100 Most Common Medical Prefixes | Medical Terminology Made Easy

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02
▶︎

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02

ACLS Drugs Review with Nurse Eunice  📚💉
▶︎

ACLS Drugs Review with Nurse Eunice 📚💉

Why is diagnosing Thoracic Outlet Syndrome so difficult?
▶︎

Why is diagnosing Thoracic Outlet Syndrome so difficult?

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer
▶︎

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

This Common Food Is Feeding Your Cancer Cells - Dr. William Li
▶︎

This Common Food Is Feeding Your Cancer Cells - Dr. William Li

🩸Phlebotomy Certification Practice Test – 50 Questions to Help You PASS!
▶︎

🩸Phlebotomy Certification Practice Test – 50 Questions to Help You PASS!

A Guide for Selection, Sequencing, and Optimal Use of HER2-Targeted Therapies in HER2+ Breast Cancer
▶︎

A Guide for Selection, Sequencing, and Optimal Use of HER2-Targeted Therapies in HER2+ Breast Cancer

Case-Based Clinical Updates in Breast Cancer | 2023 Community Cases Memphis
▶︎

Case-Based Clinical Updates in Breast Cancer | 2023 Community Cases Memphis

🩸 Phlebotomy Technician Practice Quiz – with Nurse Eunice! 🎯
▶︎

🩸 Phlebotomy Technician Practice Quiz – with Nurse Eunice! 🎯

JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
▶︎

JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC